Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
Clinical trial NCT01700673 · COMPLETED
Trial details
- NCT number
- NCT01700673
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2020-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.